• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    01 Sep 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Coforge

    Thissoftware and services company has been in thenews as its promoter, Baring PE, sold its entire stake of 26.6% through block deals on August 24. The stock gained 9.7% on the day of sale. The complete stake sale by promoters removes the impact of the periodic bulk deal sales by the promoter, which had limited the upside for the stock, despite the firm’s consistent performance. 

    According toTrendlyne Technicals, the stock has gained 15.9% in the past month, supported by its strong Q1FY24 results. The firm reported a 2.7% QoQ increase in revenue and a 44% rise in net profit during the quarter. The BFSI segment was the major revenue driver, with a QoQ growth of 4%.

    Coforge reported its highest-ever deal wins of $531 million in Q1FY24. Its average deal win in the past four quarters stands at $370 million. This has resulted in a 12-month executable order book of $897 million. Coforge has also reported a net addition of 1,482 employees in the trailing 12 months, a positive trend in contrast to the decline observed in its peers’ employee counts. Another strength lies in Coforge’s attrition rate, which is one of the lowest in the industry at 13.3% in Q1FY24.

    The management has provided a revenue guidance of 13%-16% for FY24, with a gross margin expansion of around 50 bps. The revenue growth will be backed by the huge order book, while margin expansion will be aided by moderation in onsite expenses, wage hikes, and a lower attrition rate.

    America makes up over half of the company’s Q1 revenue. The growth from this region has improved by 5.8% QoQ. However, top-line growth was impacted by EMEA (Europe, Middle East, Africa) and ROW (rest of world), which have grown by only 1%.

    Sharekhan says that the complete stake sale by promoters removes the oversupply of shares and doesn’t limit the upside. Also, the deal wins in the quarter provide visibility for revenue growth. The brokerage maintains its ‘Buy’ rating on the stock.

    2. Finolex Industries

    This pipe manufacturer hit an all-time high of Rs 250 today, a 24.2% increase in the past month following its Q1FY24 results. The company’s profit has surged by 16.2% YoY to Rs 115.3 crore, beating Trendlyne Forecaster's estimate by 5.6%. Its revenue also grew marginally and features in a screener for stocks with increasing revenue for the past three quarters.

    The company’s pipe volume has grown by 28.1% YoY, driven by seasonally strong demand from the agriculture sector, and momentum from the plumbing segment. The overall pipe manufacturing sector saw increased volumes, with competitors like Astral and Apollo Pipes reporting volume growth of 31.1% YoY and 47% YoY, respectively.

    EBITDA margin contracted by 612 bps sequentially due to the impact on profitability in the PVC (polyvinyl chloride) resin segment. This was the result of a 40.4% YoY drop in PVC resin price, which led to a lower selling price of existing inventory. Finolex’s management has guided for a 15% CAGR in pipe volume over the next five years. The company has also planned a capex of Rs 200 crore and 250 crore for FY24 and FY25, respectively, mostly for mold additions in pipe and fittings, and maintenance. 

    As of Q1FY24, the company has a net cash surplus of Rs 1,650 crore. According to Chief Financial Officer Niraj Kedia, “The surplus cash will be used for expansion, or paid out as dividend or buyback if there are no proper investment avenues.”

    ICICI Securities maintains a ‘Buy’ call on Finolex Industries on the back of margin expansion due to lower raw material prices in both agriculture and non-agriculture segments.

    3. BSE

    This banking & finance stock has surged by more than 5% for three consecutive sessions to touch an all-time high of Rs 1,138.8 per share. The boost came as its derivatives market share increased to 3.4% in August from 0% in April. Its expiry day market share also jumped to 11%. According to Trendlyne’s Technicals, the stock has risen by 31.3% over the past month, helping it to appear in a screener of stocks that have gained more than 20% in the same period.

    In addition, rumours have surfaced regarding a potential merger of the exchange with the commodity exchange MCX. This is driven by MCX’s need for  technology-related solutions for its trading platform and BSE’s potential to strengthen its position through MCX’s commodity volumes. The silence from the exchanges regarding these rumours has caused many to take the possibility seriously. 

    HDFC Securities has upgraded the stock to a ‘Buy’ rating from ‘Accumulate’, with an increased target price of Rs 1,230 per share. This indicates a potential upside of 9.2%. The brokerage believes that the BSE derivatives will grow on the back of onboarding of large member brokers, the launch of new weekly index contracts, hedging activity, and a continued increase in active traders. It expects the exchange’s revenue to grow at a CAGR of 13.1% over FY22-26, led by growth in transaction revenue.

    4. Indian Hotels Co

    This hotel chain rose by 7.9% between Wednesday and Friday, reaching a high on Wednesday, followed by new highs on both Thursday and Friday. This surge comes on the back of a healthy business outlook for the hotel industry. Given its expansive presence across India, Indian Hotels is expected to benefit from robust domestic demand and the recovery of inbound international travel to pre-covid levels. Puneet Chhatwal, the MD & CEO of Indian Hotels, says, “We continue to envelop India and are present in over 125 locations across 31 states and union territories.”

    Along with these industry tailwinds, events such as the ICC Men’s World Cup, G20 Summit, and the Miss World Beauty Contest being hosted in India are expected to boost travel. In Q1FY24, the company opened five new hotels and signed 11 new hotels (Managed Properties). The management’s plans include the opening of more than 20 hotels and a capex of more than Rs 600 crore in FY24. The company has managed to expand its network without taking on a lot of debt, and shows up in a screener for companies with improving cash flows from operations over the past two years.

    With demand continuing to outpace supply in the industry, branded hotel chains have been able to raise room rates. The company expects this favourable supply-demand balance to persist in the coming quarters, allowing it to increase room rates without sacrificing occupancy rates during the holiday season in H2FY24. Trendlyne’s Forecaster estimates the hotel chain’s annual revenue and profit to grow by 13.7% YoY and 22.6% YoY in FY24 respectively.

    5. Shoppers Stop

    This retailing company declined by over 12% in intraday trade on Monday following the exit of its Managing Director & CEO, Venugopal G Nair, effective from August 31, citing personal reasons. Having held the CEO position since November 2020, Nair’s tenure saw the company’s share price surge by over 300%. The company has appointed Kavindra Mishra, the CEO of Homestop, as the  Executive Director & CEO for a period of three years, effective from September 1, 2023.

    Under Venugopal’s leadership, the company implemented a growth plan focusing on four key aspects: private label, omnichannel, beauty business, and store expansion. In Q1FY24, Shoppers Stop introduced an affordable retail format called ‘Intune’. According to Nair, “Intune is a ‘Fashion For All’ format, which is one of our strategic initiatives to cater to young families.”

    Despite the company's assurance of maintaining the strategy developed during Venugopal’s tenure, its share price has fallen.The company also stated that it would continue to prioritize opening smaller-sized stores for enhanced efficiency and reiterated its plans to add 12-13 departmental stores for FY24. In Q1FY24, the company added six beauty stores, but the opening of the targeted 2-3 department stores was delayed.

    During the quarter, Shoppers Stop’s net profit declined by 36.4% to Rs 14.5 crore due to an increase in employee expenses, and depreciation & amortization costs. Meanwhile, its revenue grew by 4.9% to Rs 1,000.9 crore. According to Trendlyne’s Forecaster, the firm’s revenue is expected to increase by 12.3% in FY24.

    Post the announcement of the CEO's resignation, Motilal Oswal reiterates its ‘Neutral’ rating, with a target price of Rs 750. The brokerage believes that the company’s focus on growing its beauty segment, improving the private label mix, and opening smaller-sized stores along with steady store addition guidance, should aid revenues.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Example mcap screener
    01 Sep 2023

    Example mcap screener

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    31 Aug 2023
    US market comes back to life for Indian pharma | Screener: Outperforming pharma stocks

    US market comes back to life for Indian pharma | Screener: Outperforming pharma stocks

    By Tejas MD

    After hitting its all-time high of 19,991.9 on July 20, the Nifty 50 index missed the much-anticipated 20K level by a sneeze and reversed course. The benchmark is now set to post a monthly loss in August – for the first time since February this year. 

    High food inflation in July due to El Nino and a fear of contagion from the shadow banking crisis in China dampened investor sentiment in August. The 20,000 mark remains elusive so far for the Nifty. 

    The deathless zombie that is inflation also returned – it rose above the RBI’s upper tolerance limit of 6% in July. 

    Food prices had started rising in June, and accelerated in July as farmers across India were hit by unseasonal rains and heatwaves that destroyed several crops. The resulting unexpected rise in food inflation has made investors cautious. 

    But despite the Nifty falling in the past month, one industry that rose is Pharmaceuticals. In fact, this industry has outperformed the Nifty 50 over the past quarter and year. 

    The pharma sector’s rise accelerated after its Q1FY24 results, as these companies showed healthy revenue and profit growth thanks to a turnaround in the US generics market. This comes after a long period of weakness for Indian drug makers. Is the pharma sector set to continue outperforming in the coming months? Let’s find out.

    In this week’s Analyticks, 

    • Mood shift: US market back on pharma companies’ radar as pricing pressures ease
    • Screener: Pharma stocks rising more than 5% over the past month, with YoY growth in net profit and revenue, and operating margin growth

    A tough time for Indian pharma in the US may finally end

    Domestic pharma companies were the pandemic stars of 2020, but their lights dimmed in 2021 and 2022. The Nifty Pharma underperformed the benchmark Nifty 50 index by 14% and 15.5% in 2021 and 2022 respectively. The US generics market, which had been a cash cow for Indian pharma in the past decade, failed to deliver after the US regulator encouraged more competition in this space. The resulting pressure on prices hit profitability hard. 

    But the prolonged period of intense competition in the US saw many losers. On Cipla’s Q1FY24 earnings call, Umang Vohra, Managing Director and Global CEO said, “A large number of US companies are either amalgamating, merging, or going bankrupt. That is eliminating a number of players in the system.”

    The pricing pressure has as a result, eased in the past two quarters and the management of all major Indian companies see a better outlook in US generics for FY24. 

    Better supply, new launches and lower raw material costs are also driving the generics segment’s rebound.  

    The two tough years for Indian pharma saw them improvising more. Drug makers like Sun Pharma, Cipla and Zydus Lifesciences diversified their product mix into complex generics, specialty drugs, peptides and injectables, where the pricing pressure was lower.

    Now with the generics segment also recovering, pharma companies are reaping benefits from their efforts in higher-margin complex generics as well as the generics segment.  

    Pharma companies outperform the Nifty 50 over the past quarter and six months

    US pharma market outperforms Indian market in FY23

    Revenue from the US generics market for top pharma companies rose 16% YoY in FY23 and outperformed the domestic market’s growth by a big margin. 

    US generics market turns around while the Indian market growth moderates

    Top pharma companies’ US business rose sharply in Q1FY24 while Indian business growth moderated.

    US and International businesses drive Indian pharma companies’ revenue in Q1FY24

    New product launches with drug exclusivity like Revlimid helped grow profit margins in the past two quarters. Companies are focussing on multiple new launches, as margins here are higher before competitors launch alternatives.

    To launch a new product in the US, companies need approval from the US Food and Drug Administration (USFDA) via the abbreviated new drug application (ANDA). India’s share in ANDA approvals was at 49% (a record high) of all ANDAs approved in FY23.

    Indian drug makers’ ANDA approval share bounces back after a dip in 2021


    Falling raw material and freight costs help margins recover

    In 2021 and 2022, raw material and freight costs were at an all-time high for pharma companies. But in 2023, raw material and freight costs are on a downtrend. 

    Input prices fall YoY after reaching all-time highs in 2022

    Input prices of major raw materials like para amino phenol and antibiotics have fallen over the past year and helped pharma companies’ margins rise QoQ and YoY in Q1FY24. 

    New product launches and falling input prices help margins rise in Q1

    However, active pharmaceutical ingredient (API) manufacturers like Divi's Laboratories are still facing margin pressure, as these companies import a higher percentage of their inputs (key starting materials) from China, which has pricing power. 

    China’s share in India’s key starting materials import rises in FY23

    API manufacturers also have to compete with China in exports. If China's API exports ramp up, these bulk drug manufacturers’ margin pressures could persist through the year. 

    Revenue visibility is high, but growth opportunities are murky

    The Indian pharma market (IPM) is expected to grow at a steady CAGR of 8-10% over the next five years. Key factors that drive the IPM are volume growth, price hikes and new product launches. The main reason for IPM growth moderating in FY23 is the slower volume growth.

    Indian pharma industry grows 9.3% in FY23 led by price hikes

    Pharma companies have tried to offset this with price hikes, but they don’t have complete pricing power. The National Pharmaceutical Pricing Authority sets ceiling prices for several essential drugs that are part of the National List of Essential Medicines (NLEMs).

    These ceiling prices are revised in line with changes in the wholesale price index (WPI) to factor in inflation on a YoY basis. 

    Number of drugs covered under NLEM is on a steady rise

    For non-NLEM products, Indian pharma companies can increase prices by up to 10% every year.

    The magic pill for pharma: a diversified product and geo mix

    Banking on just US business growth could be risky for Indian pharma companies, as USFDA regulations and inspections can play spoilsport. For example, Cipla’s share fell over 7% after its Pithampur unit got eight observations from the USFDA in February. This issue is yet to be resolved. This is where a diversified product and geo mix comes into play to reduce risks. 

    Like any other industry, pharma goes through different cycles as business dynamics change. In a Crisil discussion, Lakhshay Kataria, CFO of J B Chemicals & Pharmaceuticals said, “Two years ago we were apprehensive about the US and international market, but now the US market looks lucrative. So, diversification is key and companies with varied product and geo mixes can ride the winds of change in different geos, and grow at a faster rate”.


    Screener: Pharma stocks that are rising over 5% in the past month, with net profit and margin growth

     Natco Pharma’s revenue growth is among the highest in the pharma sector

    This week, we take a look at pharma stocks that have performed better than the sector in Q1FY24. This screener shows pharma stocks which have risen more than 5% in share price with growth in Q1FY24 revenues, net profit and operating profit margin. 

    Major stocks in the screener are Caplin Point Laboratories, JB Chemicals & Pharmaceuticals, Lupin, Natco Pharma and Ajanta Pharma.

    Caplin Point Laboratories rose 20.9% over the past month, the highest among the pharma stocks. It rose on the back of a 14.2% YoY growth in its revenue in Q1FY24, aided by improved sales in the semi-regulated markets of Latin America and Africa which contributed to 86% of its revenue. The company’s net profit increased by 21.7% YoY, which helped in expanding its operating profit margin.

    Natco Pharma gained 8.2% over the past month owing to a 28.9% YoY growth in its revenue in Q1FY24, the highest in the pharma sector. Improvement in sales from gRevlimid, domestic and agrochemicals businesses helped revenues improve. Its net profit grew by 31.2% YoY thanks to a reduction in employee benefit expenses.

    Lupin has risen 12.7% over the past month due to a 28.6% YoY growth in its revenue in Q1FY24. Improvement in sales from North America, India and active pharmaceutical ingredient (API) businesses led to topline growth. The company also posted a net profit of Rs 452.3 crore in Q1FY24 compared to a loss in Q1FY23. 

    You can find more screeners here.

    Signing off,

    The Trendlyne Team

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    30 Aug 2023
    Five analyst picks this week

    Five analyst picks this week

    By Suhas Reddy

    1. Pidilite Industries:

    Geojit BNP Paribas upgrades its rating on this adhesives manufacturer to ‘Buy’ from ‘Hold’ and raises the target price to Rs 2,792 from Rs 2,726. This implies an upside of 8.4%. In Q1FY24, the company’s net profit rose 32.4% YoY to Rs 468.2 crore and revenue grew by 5.6% YoY. Analyst Anil R says, “Performance in Q1FY24 was driven by volume growth in domestic Consumer & Bazaar (C&B) business segments.” He also points out that a reduction in raw material prices along with operational efficiencies aided healthy growth in net profit. 

    The firm’s management expects deeper expansion into rural areas, uptick in construction activity and a good monsoon to push growth in the near term. Also, the company sees exports rising in Q2FY24 and Q3FY24. 

    In light of Pidilite’s healthy Q1 performance and the recent correction in the stock price, Anil R believes the firm is trading at an attractive valuation, thus the upgrade in recommendation and target price. He expects the company’s net profit to grow at a CAGR of 30% over FY23-25.

    2. 3M India:

    ICICI Securities maintains its 'Buy' rating on this industrial machinery company with a target price of Rs 35,200, implying an upside potential of 11.5%. Analysts Aniruddha Joshi, Karan Bhuwania, and Nilesh Patil have a positive outlook, given the growth of 3M’s end-user industries such as automotive, infrastructure, and manufacturing. These factors bode well for 3M India.

    The analysts highlight the company's pricing power, successfully transferring added costs and boosting EBITDA margins to 15.3% in FY23 from 11.7% in FY22. They foresee growth through new products and strategic partnerships, coupled with expenditure reduction in ad spend and working capital, driving improved FY23 margins.

    Additionally, the analysts are of the opinion that the company boasts robust brand value and stands to gain from its well-established distribution network. They also factor in 3M India's global relationships with major manufacturers. They believe that 3M India should benefit significantly from its access to the technological resources of its parent company.

    3. Mahindra & Mahindra:

    Sharekhan maintains its buy call on this automobile manufacturer and raises its target price to Rs 1,736. This indicates an upside of 9.9%. Analysts from Sharekhan say, “Mahindra & Mahindra strategically aims to strengthen positioning in the overseas market with the introduction of global products.” 

    The analysts remain optimistic as the company introduced multiple concept vehicles to cater to domestic as well as international markets in the tractor, E-SUV, and pick-up vehicle segment. Mahindra launched the OJA platform in the lightweight tractor segment and Thar.e in the electric SUV segment. Even though historically the company’s operating performance was largely dependent on the tractor segment, the analysts now believe that the auto segment will drive its operating performance in the coming years due to increasing volumes going ahead. 

    The analysts maintain the call on the back of a robust order book in the private vehicle segment, market leadership in the tractor segment, opportunity to grow in farm machinery and its road map for the electric vehicles space.

    4. CIE Automotive India:

    ICICI Direct assigns a ‘Buy’ rating to this auto parts manufacturer with a target price of Rs 625, indicating an upside of 21.4%. The company’s management plans to incur a growth capex of approx 5% of its sales. At the same time, it plans on improving operational efficiencies in its European operations. 

    Given the new order wins in the electric vehicle (EV) domain accompanied by  the growing domestic market, cyclical upswing in commercial vehicle space, and steady demand for two-wheelers, the analyst Shashank Kanodia says, “CIE is well poised for double-digit revenue growth and a further improvement in margins.”

    The analyst believes that India is being looked at as a credible alternate manufacturing hub amid the China +1 trend, and so will be a focus for auto ancillaries. He also remains positive about the company as it is actively de-risking its existing business product profile by entering into EV products, which provide growth longevity. He assigns the call on the back of improving margins, return ratios and consistent healthy cash flow generation.

    5. Bajaj Auto:

    Axis Securities maintains a 'Buy' rating on this 2/3 wheeler company with a target price of Rs 5,400, indicating an upside of 15.8%. Analysts Aditya Welekar and Shridhar Kallani are optimistic about the company's future due to its focus on electric vehicles (EV) and premium motorcycles, which align with changing industry trends.

    Despite lower sales volumes in FY23, analysts at Axis Securities believe the company performed well. They attribute this success to higher average selling prices (ASPs) of their vehicles, driven by price hikes, increased domestic sales, and a larger share of the 125cc+ segment and three-wheeler sales.

    The analysts also highlight the company's strong brand value, citing its exclusive dealership networks for KTM and the recent launch of Triumph motorcycles. They consider the company's investment plans for FY24 as a significant growth driver, with Rs 1,000 crore allocated for expansion, which includes Rs 500 crore specifically for the EV segment.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    29 Aug 2023

    Chart of the week: Top CEO salaries across major Indian sectors

    By Akshat Singh

    One thing CEOs cannot avoid is attention to their compensation packages. If you are in the C-suite of a listed company, your salary is inevitably going to be discussed and compared to your peers. There is danger on the upside (“Aren’t they getting too much?”) and on the downside (“Maybe they are not a great CEO.”) 

    But these salaries also showcase a company's values, their talent retention strategies, and dedication to fairness. Narayana Murthy, the founder of Infosys, was for example extremely against high salaries for the top management, saying that a CEO salary should not be more than 25X of the least paid employee. That rule, if we look at the top paid CEOs, has long been thrown out of the window. 

    CEO salaries are also potential red flags. For instance, a big YoY jump in CEO pay when the company’s revenue or net profit fell considerably in the same period raises corporate governance questions. 

    In this edition of Chart of the Week, we explore major market sectors to examine the highest CEO salaries from Trendlyne’s CEO salary dashboard, and compare them as a percentage of their companies' FY23 revenues.

    We begin our analysis with the most highly-paid sector, software and services. Thierry Delaporte, the Managing Director & CEO of Wipro, leads with an annual remuneration of Rs 82.4 crore in FY23. This is a 3.3% rise from his remuneration in FY22 as the company’s revenue grew by 14% YoY in FY23 while the net profit declined by 7.2% YoY. His earnings account for 0.1% of the company’s FY23 revenue. 

    In the same sector, Sandeep Kalra, the Executive Director & CEO of Persistent Systems, earns an annual salary of Rs 61.7 crore in FY23, a substantial 31.6% rise from FY22. This is 0.7% of the company’s FY23 revenue of Rs 8,421.2 crore. The company did very well during the IT slowdown, posting an increase in net profit by 33.4% YoY in FY23. 

    Coming in third is Nitin Rakesh, the Managing Director & CEO of Mphasis, who receives an annual remuneration of Rs 59.2 crore in FY23, equivalent to 0.4% of the company’s FY23 revenue of Rs 13,960.1 crore.

    Turning our attention to the banking and finance sector, Keki M Mistry, the Vice-Chairman & CEO of Housing Development Finance Corp, emerges as a prominent figure with an annual salary of Rs 20.8 crore in FY23. However, it's worth noting that HDFC is delisted due to the significant merger involving HDFC and HDFC Bank. As of August 2023, Keki Mistry is no longer CEO and is to be a ‘strategic advisor’ to all the financial ventures of Poonawalla Group. VP Nandakumar, the Managing Director & CEO of Manappuram Finance, receives an annual remuneration of Rs 18.6 crore in FY23, a 6% increase from FY22. This increase can be attributed to a 12.6% YoY growth in net profit in FY23. This is  0.3% of the company’s FY23 revenue of Rs 6,749.9 crore. 

    Shalabh Saxena, the Managing Director & CEO of Spandana Sphoorty Financial, comes in third, and draws an annual salary of Rs 15.7 crore in FY23, constituting 1.1% of the company’s FY23 revenue of Rs 1,477 crore. The CEO's salary rose to 15.6 crore from 15.7 lakh in FY22 due to the share based payment of Rs 15.1 crore made by the company in FY23.

    In the automobiles and auto components sector, Jayadev Galla, the Chairman, MD & CEO of Amara Raja Batteries, commands an annual remuneration of Rs 52.6 crore, marking a 38.5% increase from FY22. The rise in remuneration can be credited to a surge in net profit of 35.5% YoY for the company in FY23. His earnings make up 0.5% of the company’s FY23 revenue of Rs 10,480.2 crore. 

    Meanwhile, Rajiv Bajaj, the Managing Director & CEO of Bajaj Auto, gets an annual salary of Rs 47.6 crore in FY23, reflecting a modest 4.3% increase from FY22. This remuneration constitutes 0.1% of the company’s revenue of Rs 37,642.9 crore in FY23.

    Vivek Vikram Singh, Managing Director & Group CEO of Sona BLW Precision Forgings comes in third. He was paid Rs 12.5 crore as remuneration in FY23. His salary was reduced by 14.2% from FY22 due to a muted growth of 9% in the company’s net profit in FY23. 

    In the research & development heavy pharmaceutical and biotechnology sector, Kiran S Divi, the Whole-Time Director & CEO of the family-run Divi’s Laboratories, holds the highest annual remuneration of Rs 24.8 crore in FY23, despite experiencing a 34.2% reduction in pay from FY22. The company saw a fall in net profit of 38.4% YoY in FY23. His earnings represent 0.3% of the company’s revenue in FY23. Chava Satyanarayana, the Executive Director & CEO of Laurus Labs, follows with an annual salary of Rs 18.6 crore in FY23, followed by Umang Vohra, the Managing Director & Global CEO of Cipla, who earns Rs 17.5 crore.

    Lastly, we look at the cost-sensitive metals and mining sector, where TV Narendran, the Managing Director & CEO of Tata Steel, commands an annual remuneration of Rs 18.7 crore in FY23, marking a 4.3% decrease from FY22. This fall can be associated with a fall in net profit of 78.2% YoY in FY23 . 

    Sunil Duggal, the Whole-Time Director & CEO of Vedanta, receives an annual salary of Rs 14.6 crore. Although the company’s net profit fell by 43.8% YoY in FY23 his compensation increased by 33.8% in the same period. 

    Jayant Acharya, Joint Managing Director & CEO of JSW Steel comes in third. He was compensated with Rs 10.7 crore as remunerations in FY23. His salary surged by 137.1% from FY22 levels although the company's net profit fell by 80% in FY23.

    For more details on annual CEO salaries, you can check Trendlyne’s CEO Salary Dashboard.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener screener test
    29 Aug 2023

    screener test

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener High Checklist Score Stocks
    25 Aug 2023

    High Checklist Score Stocks

    Stocks with high positive checklist score and low negative checklist
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    25 Aug 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1.Linde India

    This industrial gases producer touched an all-time high of Rs 6,165 on Wednesday after receiving a Letter of Acceptance (LoA) from Indian Oil Corporation (IOCL), for an  order for the installation, operation, and maintenance of an air separation unit at IOCL’s Refinery in Panipat for 20 years. 

    Linde India has risen by 27.4% over the past month and made it to a screener of companies with strong momentum. The company, during its annual general meeting, stated that the industrial gases market is poised for robust growth of around 9% in the near term. It anticipates an increase in demand for gas and improved opportunities from the steel sector, driven by consolidation, and productivity increases. The company’s positive outlook is also supported by the healthcare sector’s growth prospects. Linde India foresees robust growth in SPC (special purpose chemicals) products, while also expecting an uptick in nitrogen opportunities.

    The company released its Q1FY24 results earlier this month. Its net profit has dropped by 41.9% to Rs 99.9 crore due to increasing costs of raw materials, power and fuel, and other expenses. However, its revenue improved by 23% to Rs 721.1 crore, led by strong performance in the gases, related products, and project engineering segments. 

    Linde India ranks high on Trendlyne’s checklist with a score of 69.9%. It is currently trading in the ‘Strong Sell’ zone, based on the time spent below its current PE, suggesting expensive valuations.

    2.  GMR Airports Infrastructure:

    This airport development company rose by over 9.4% on Thursday. The stock touched a 52 week high of Rs 66.8 in intraday trade today. It has also surged by 15.9% over the past week till Friday. The firm shows up in a screener for stocks trading above their short, medium and long-term moving averages. This upswing in share price comes on the back of increased passenger traffic in its airports. In Q1FY24, the company’s revenue jumped by 40.2% YoY to Rs 2,017.6 crore, beating Trendlyne Forecaster’s revenue estimates by 1.1%. Additionally, its net loss narrowed to Rs 29.8 crore from Q1FY23’s Rs 137 crore, aided by a one-time gain of Rs 76.1 crore from asset sales.

    GMR Airports Infra has benefitted from the rise in air travel demand in India, as it currently operates international airports in Delhi, Hyderabad, and Goa. In Q1FY24, the passenger traffic at Delhi and Hyderabad international airports grew by 18% and 24% YoY respectively. The management expects the positive momentum in traffic to continue, fueling growth. The addition of new routes and increased airline capacity are expected to boost air traffic.

    To meet the growing demand, the company has been expanding its terminals in Delhi and Hyderabad with a capex of Rs 17,000 crore. This will increase the terminal capacity in Delhi by 51.5% to 100 million passengers (pax) and in Hyderabad by 183.3% to 34 million pax by the end of FY24.  

    ICICI Securities believes that the merger of GMR Airports with GMR Airports Infrastructure will simplify the firm’s corporate structure and lead to substantial value creation for its shareholders. The company received approval for the merger from the Competition Commission of India in Q3FY23.

    3. Lemon Tree Hotels: 

    This hotel company has risen by 10.9% over the past week to its all-time high of Rs 111.2 per share. This boost follows the announcement of the company signing license agreements for two properties in Bhubaneswar and Kasauli. This rise helps it to appear in a screener of stocks with prices above short, medium and long-term moving averages. The properties are expected to be operational by FY25 and FY26, respectively. 

    Lemon Tree Hotels posted its Q1FY24 results on August 11, with a 69.4% YoY increase in net profit to Rs 23.5 crore. Its revenue has also improved by 15.7% YoY to Rs 222.2 crore, aided by growth in gross average room rate (ARR), revenue per available room (RevPAR), and occupancy. However, its revenue and net profit missed Trendlyne’s forecaster estimates by 3.1% and 12.6%, respectively. 

    Its margins contracted by 834 bps QoQ on account of higher advertising expenses and employee costs due to new hotel openings. Lemon Tree has planned a capex of Rs 40 crore for FY24 to revamp its budget hotels, which is expected to impact EBITDA margins by 200-250 bps. 

    Speaking about the results, the company’s Chairman and Managing Director said, “Growth in the coming quarters will be from two new hotels opening in October 2023. Also, our asset-light model will help accelerate growth in our managed and franchised portfolio.”

    IDBI Capital maintains its ‘Buy’ call on Lemon Tree Hotels, with a target price of Rs 110 per share. The brokerage believes that the company will benefit from increased demand in leisure travel, corporate travel, and meetings, conferences and exhibitions (MICE). The demand-supply mismatch in the near-term also seems favourable for overall earnings growth of the industry. It expects the company’s revenue to grow at a CAGR of 33.2% over FY22-25.

    4. Bharat Forge: 

    This industrial products manufacturer has risen by 6.8% in the past week and hit an all-time high of Rs 1,052.1 on Thursday. The price rise comes as the company’s defence arm, Kalyani Strategic Systems, won an export order worth 93.9 million euros (approx Rs 850 crore) to supply components and armoured vehicle chassis.

    In Q1FY24, Bharat Forge’s net profit grew by 25.9% YoY to Rs 223.4 crore, beating Trendlyne Forecaster’s estimate by 7.9%. It’s revenue also increased by 36.7% YoY, beating the estimate by 20.1%. The revenue growth was led by defence and passenger vehicle component exports. The company’s foreign subsidiaries have particularly excelled in revenue growth, driven by the aerospace segment. Orders from the US for class 8 trucks are also seeing good traction. Its EBITDA margin has fallen marginally by 20 bps YoY due to an increase in raw material expenses. The company also appears in a screener for stocks with increasing revenue for the past four quarters.

    Bharat Forge's current order pipeline stands at Rs 2,200-2,300 crore, scheduled to be executed over the next 18 months. Defence and aerospace orders worth around Rs 1,700 crore and Rs 500 crore, respectively, are expected by the end of FY25.

    Motilal Oswal reiterates its ‘Buy’ call on Bharat Forge and estimates a revenue and profit CAGR of 13% and 85% respectively over FY24-25 The expected surge in the order book and an upswing in exports are projected to drive revenue growth. The brokerage maintains its stance on the back of executions of the orders in the coming quarters.

    5. KEI Industries: 

    Thiselectrical equipment stock has risen by 8.6% in the past week, according toTrendlyne Technicals. KEI Industries is among India’s top three wire and cable manufacturers, with a product portfolio ranging from housing wires to Extra High Voltage (EHV) cables. KEI derives 63% of its revenue from cables, 6% from EPC, and 31% from wires. 

    The stock has declined by 6.5% after announcing its Q1FY24 results. KEI Industries reported a revenue growth of 13.9% and a profit growth of 17% YoY. The jump in revenue was led by a 22% increase in cable business volume. KEI reported an EBITDA margin expansion of 5 bps YoY – the muted margin growth was on account of higher expenditure on IPL advertisements, and capacity constraints. The firm's strategy to diversify itself into the retail business has resulted in the retail segment contributing 44% of the revenue, with the housing wires segment driving retail sales. KEI’s current order book stands at Rs 3,567 crore. It shows up in ascreener for companies that are efficiently managing assets to generate profits.

    KEI saw a capacity crunch in Q1FY24, impacting cable manufacturing volumes. This has resulted in KEI running at full capacity and achieving only 22% volume growth in cables, as compared to its peers,Polycab India (42%) andHavells India (24%). However, the brownfield expansion of cable manufacturing is set to be completed in Q2FY24, which should address the capacity issues. 

    Anil Gupta, the Managing Director of KEI Industries, has provided a guidance of 17% revenue growth for FY24, with EBITDA margins maintained at current levels of 11%. KEI has also planned a capex outlay of Rs 1,000 crore over the next three years for its capacity expansion. The stock is in the ‘Sell’ zone, according to the time spent below its current PE.

    BOB Capital sees growth traction in its export orders and cable business. The improvement in working capital is margin accretive. Due to the recent stock price appreciation and its capacity constraints, the stock has been downgraded from ‘Buy’ to ‘Hold’.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    25 Aug 2023
    Climate change comes for Indian industries | Screener: companies outperforming in climate-hit sectors

    Climate change comes for Indian industries | Screener: companies outperforming in climate-hit sectors

    By Deeksha Janiani

    Imagine being trapped in a car for three days without food or water as a fire rages in your city. This harrowing experience happened to thousands of families caught in the recent wildfiresin the Hawaiian island of Maui. The lucky ones reached safety with singed hair and faces blackened by soot. By the time the fire receded, over a 100 people were dead and around 850 are still missing. 

    Just a month ago, Rhode Island in Greece saw its biggest-ever fire evacuation, relocating nearly 30,000 people to safety. And last week, people were being evacuated from wildfires across British Columbia in Canada.

    The mercury is rising like never before - Southern Europe saw unusual summer heat, US states have suffered historic droughts. At an Iran airport, the heat index reportedly hit 66 degrees celsius. In the critical trade route that is the Panama Canal, which moves half a billion tons of cargo every year, low water levels are forcing ships to load only partially, and wait for four days or more (and 20 days in some cases) to cross the waterway. In India, we endured our hottest February ever, followed by unseasonal rains. 

    Such extreme climate events are threatening human lives and affecting world economies. UN Secretary General António Guterres described these changes as a ‘crisis multiplier’, and its effects are becoming increasingly undeniable. Indian CEOs say that it is beginning to impact businesses and balance sheets.  

    In this week’s Analyticks:

    • Nature’s fury hits certain pockets of the economy and industry in India
    • Screener: Growth outperformers in sectors affected by climate change in India

    Let’s get into it.


    Climate change unnerves Indian farmers, consumers and companies in 2023

    Among this year’s bestsellers is Jeff Goodell’s The Heat Will Kill You First, which looks at our rapidly heating planet. He provides some sobering numbers: land animals are moving upwards one mile every year to cooler regions. 489,000 people are dying every year from extreme heat - nearly double the number killed by firearms annually. And global agricultural production has fallen by 21% in the last two decades due to rising heat and drought. 

    The average global temperature change consistently exceeded one degree Celsius every year from 2015-2020. Humans are now seeing temperatures never experienced before in our history.

    The increase in mean temperatures is resulting in heatwaves, erratic rainfall patterns, and water shortages everywhere.

    Global heat escalates throughout the 21st century

    India is not spared from these impacts. It experienced extreme weather events for 84 out of the 120 days in the first four months of 2023, according toITC’s chairman Sanjiv Puri. El Nino has adversely impacted the monsoon season as well. As Indian companies grapple with this severe weather, the effects are turning up in their financials.

    India's rainfall is uneven and deficient so far, threatening agri yields 

    Ritesh Tiwari, CFO at Hindustan Unilever, pointed out an interesting fact in the recent earnings call: “Quantity, timing and placement of the rain - all three have to work to ensure that the monsoon supports agricultural growth and rural growth.” And all three factors have been disrupted this season. 

    The monsoons began late in 2023 and have been below average in August. Karnataka faced a challenging situation in June, as  water levels in the Krishna and Kaveri river basins were significantly low, impacting coarse cereal production. The state is still running in a rainfall deficiency. 

    Below-average rainfall persists, and state-wise distribution remains uneven

    Uttar Pradesh, India’s largest food grains producer, is also experiencing a rainfall deficit. This is likely to impact the yields of kharif crops like paddy, maize and millets. Unexpected flooding in states like Punjab and Haryana, major rice producers, is raising concerns about this season's rice output as well. 

    To control rising prices, the Indian government banned white rice exports in July. Since India is the world’s largest rice exporter, this has raised food insecurity risks for importing countries. 

    India dominates global rice exports with over one-third market share

    The sugar output for the current marketing season ending September 30 is also expected to decline, due to poor rainfall in cane-producing states like Maharashtra and Uttar Pradesh. 

    Sugar production and exports set to fall

    Retail inflation in India spikes as food prices climb

    The RBI’s efforts to tame retail inflation through a series of interest rate hikes, and the decline in global commodity prices had paid off for a while. However, the erratic weather events of 2023 have again put pressure on the Central Bank. 

    India’s retail inflation spikes again

    Consumer price inflation has crossed the 7% mark for the first time since September 2022. This is owing to the rise in prices of key vegetables, cereals and pulses.

    Tomatoes, a staple in Indian cooking, reached Rs 250/kg in some regions, prompting some tomato sellers to hire security guards, and quick-service restaurants like Burger King and McDonalds to omit it from their burgers. 

    Vegetables contribute the most towards July CPI food inflation

    With uneven monsoons threatening the yield of kharif crops as well, this inflation spike does not look like an isolated event. The increase in prices could also dampen rural demand, which had just started to recover for FMCG players. 

    Unpredictable weather hits FMCG, white goods and agrochemical makers

    This summer season has had unexpected twists. Product categories and segments that flourished in previous summers due to heatwaves found themselves in a downturn this year, thanks to unseasonal rains. Demand for fruit beverages, carbonated drinks, ice creams, cooling hair oils, ACs, fans and coolers declined YoY between April and June. 

    Commenting on this, Mohit Malhotra, CEO at Dabur, said, “When it rains, people tend to stay indoors, impacting the sales of eating and drinking outlets. This affects our beverage portfolio.” Notably, the company gets 30% of its beverage demand from out-of-home consumption. 

    FMCG players are seeing underperformance in the food and beverages business

    Brands like Glucon-D, Real Fruit Juice and Tropicana saw lower sales growth in Q1. These are manufactured by Zydus Wellness, Dabur and Varun Beverages respectively. Among consumer durable makers, Blue Star’s AC segment faced sluggish revenue growth. Voltas and Havells did better due to market share gains.

    Havells and Voltas see healthy growth in the AC business

    Domestic agrochemical players were already going through a rough patch. Unseasonal rainfall resulting in a delayed kharif season has only amplified their woes.

    India needs to step up as climate change intensifies

    According to the World Meteorological Organization, there is a high chance of temperature rise exceeding 1.5 degrees in the next five years. And with this, the climate goals in the Paris Agreement may become very difficult to achieve. 

    India’s faraway target of achieving net zero emissions by 2070 might come with a heavy cost to its GDP by 2050. The agricultural sector will also face consequences. According to India’s agriculture ministry, climate change may reduce wheat and rice yields by over 19% by 2050. Poor farm incomes will hurt livelihoods, and hit FMCG and auto sectors. 

    India’s 2070 goal is not sufficient to counter climate change

    Scientists’ repeated warnings about the dire effects of climate change are now becoming a reality. Humans are notoriously bad at paying attention to warnings for events that might happen far in the future - but as climate change accelerates, the world as we know it is immediately at risk. Governments need to move quickly with incentives and investments, to change the course that we are on. 


    Screener: Stocks outperforming their sectors’ revenue and net profit growth - Climate change special

    Bikaji Foods leads in net profit growth outperformance 


    In this edition, we take a look at outperformers in sectors where revenue and net profit growth were affected by extreme climate change in Q1FY24. This screener shows companies that have outperformed their climate-impacted sectors in terms of net profit growth and revenue growth.

    The sectors include FMCG, food & beverages, consumer durables and chemicals & petrochemicals (agrochemicals industry mainly). 

    Major stocks that appear in the screener are Bikaji Foods International, Kaynes Technology India, Jyothi Labs, Emami, Polycab India and United Spirits.

    Bikaji Foods’ revenue and net profit outperformed the FMCG sector by close to 13 and 146 percentage points respectively in Q1FY24. Revenue growth was aided by increased sales volumes in ethnic snacks, packaged sweets and western snacks. Net profit growth was helped by the reduction in input and finance costs.

    Kaynes Technology saw its revenue and net profit outperform the consumer durables sector by 37 and 119 percentage points respectively in Q1FY24. Its revenue rose due to higher demand from the industrial, railways, automotive, aerospace and IT segments. The company is a contract manufacturer for electronics and is not exposed to the B2C segment. 

    United Spirits beat the food & beverages sector in terms of revenue and net profit growth by nearly 133 and 68 percentage points, respectively, during the quarter. The spirits maker’s revenue increased on the back of healthy volume growth and the initiation of IPL’s five-year media rights. 

    You can find some popular screenershere.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    22 Aug 2023
    Five analyst picks with high upsides

    Five analyst picks with high upsides

    By Satyam Kumar

    This week we take a look at stocks with high upside from analysts post Q1 results. 

    1. Godrej Industries: 

    ICICI Securities maintains a 'Buy' rating on this holding company of the Godrej Group, with a target price of Rs 764, indicating an upside of 53.6%. In Q1FY24, the company's revenue increased by 12% YoY to Rs 4,505.7 crore, while net profit decreased by 30.9% YoY. This profit decrease was attributed to revenue declines in the chemical business due to strong headwinds in the industry. 

    Despite the fall in profit, analysts Aniruddha Joshi and Nilesh Patil remain optimisticas the company continues to generate considerable value from its listed subsidiaries, namely Godrej Properties and Godrej Agrovet (profit rose 174.3% YoY and 27.3% YoY, respectively). 

    The analysts estimate the company's value to be trading at a discount of 66% by considering the target prices for its subsidiaries along with a 50% holding discount. The company also operates Godrej International and has initiated its housing finance business under Godrej Capital. They believe that the listed subsidiaries will gain from the economic revival and the ongoing migration of value from unorganised to organised sectors.

    2. Crompton Greaves Consumer Electricals: 

    HDFC Securities maintains its ‘Buy’ rating on this household appliances manufacturer with a target price of Rs 400, implying an upside of 34.2%. In Q1FY24, the company’s net profit fell by 2.2% YoY to Rs 118.3 crore and revenue grew by 0.8% YoY. 

    Analysts Naveen Trivedi, Paarth Gala and Riddhi Shah see the firm’s Q1FY24 performance as a mixed bag. While its revenue growth beat their expectations by 4.4%, margins fell short. They attribute the margin decline to increased advertising expenses, delayed price hikes, and higher research & development expenses. They add, “These costs are upfront in nature, thereby impacting operating margin.”

    Although the analysts expect margin pressure to persist in the near term, they foresee gradual revenue growth. They project the company’s revenue to grow at a CAGR of 12.4% over FY23-26. 

    3. Dilip Buildcon: 

    Geojit BNP Paribas maintains its ‘Buy’ call on this construction company with a target price of Rs 367, indicating an upside of 19.5%. In Q1FY24, the company reported an EBITDA margin expansion of 500 bps YoY to 12.8%, despite a marginal rise of 1.3% in revenue. Analyst Antu Eapen Thomas says that the margin expansion was led by a fall in input costs and better absorption of overheads. The company’s management expects execution to pick up pace and guides a revenue growth of 8-10% with an EBITDA margin of 13% in FY24. 

    Thomas believes that Dilip Buildcon has strong growth visibility for the next two years, with its order book in Q1 reaching Rs 24,051 crore, which is 2.4x the trailing twelve-month revenue. He expects a recovery in execution starting from H2FY23 on account of improvements in inflows and the completion of legacy projects. He concludes, “We maintain our stance due to expected improvements in execution and margins.”

    4. KNR Constructions: 

    Axis Direct keeps its ‘Buy’ rating on this construction company but lowers the target price to Rs 305 from Rs 325. This implies an upside of 12.8%. In Q1FY24, the firm’s net profit surged by 53% YoY to Rs 137.1 crore and revenue grew by 0.1% YoY. 

    Analysts Uttam K Srimal and Shikha Doshi believe that the company is well-placed to capitalise on the Centre’s increased infrastructure spending, given its presence in diverse segments like roads, railways, metro and urban infrastructure. They add, “With newer opportunities emerging in various infra-related sectors, the diversification strategy augurs well for the company.”

    The analysts believe the firm’s order book stands strong despite a slowdown in order inflows. They expect the order inflow to pick up in the coming quarters, led by road projects. Srimal and Doshi estimate the firm’s revenue to grow at a 12% CAGR over FY23-25. 

    5. Vinati Organics:

    Motilal Oswal reiterates its ‘Buy’ call on this specialty chemicals company but reduces the target price to Rs 2150. This indicates an upside of 18.7%. In Q1FY24, the company’s revenue stood at Rs 446.4 crore (down 15% YoY), which is 9% below the brokerage’s estimate. Analysts Aman Chowdhary and Rohit Thorat say, “About 90% of the revenue decline was due to reduced volumes.” However, they expect demand to recover in H2FY24. 

    The analysts are cautious on the back of lower offtakes and underperformance of ATBS (40% of total revenue) in Q1. The delay in the plan to expand ATBS capacity by 50% until the end of FY24 also contributes to their expectation. The management sees a muted performance in FY24. 

    The analysts maintain optimism as Vinati Organics’ arm Veeral Organics is set to commence production of guaiacol, anisole and iso-amylene by the end of FY24, which they believe will drive the company into the next leg of growth. They forecast a revenue CAGR of 17% over FY24-25, translating into an EBITDA CAGR of 19%.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    2
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd